Racura Oncology LtdASX: RAC

MD Anderson Preclinical AML Study on Zantrene Published

Feb 23, 2022 at 3:59 AM UTC · Issued by Racura Oncology Ltd

Race Oncology Ltd has released a press release.

View Attachment